London politicians are urging the provincial government to review the operations of for-profit pharmacies that dispense drugs for addiction treatment. The call comes amid growing concerns about oversight and patient safety in these facilities.
Concerns Raised at Medpoint Care Pharmacy
Recent gatherings at Medpoint Care Pharmacy on Dundas Place in London, Ont., have drawn attention to the issue. On April 15, 2026, community members and advocates assembled outside the pharmacy to voice their worries about the lack of regulation and potential conflicts of interest in for-profit addiction treatment.
Provincial Review Sought
Local politicians have formally requested that the province conduct a comprehensive review of all for-profit pharmacies involved in dispensing addiction medications. They argue that current oversight mechanisms are insufficient and that patients may be at risk of inadequate care or exploitation.
“We need to ensure that these pharmacies are prioritizing patient health over profits,” said a city councilor involved in the initiative. “A provincial review will help identify gaps and recommend necessary changes.”
Broader Implications
The push for a review is part of a larger debate about the role of private entities in addiction treatment. Critics argue that for-profit models can lead to overprescribing or inappropriate dispensing of medications, while proponents claim they increase access to care.
The provincial government has yet to respond to the request, but the issue is expected to gain traction as more communities raise similar concerns.
